BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. KLK3, calcium channel activity, Breast Cancer, Intestine, Nosology, Lipitor, rs2476601)
Bookmark Forward

QuickView for N-Myc (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal brain
  2. Hematopoietic stem cell of bone marrow
  3. Granulocyte-macrophage progenitor cell of bone marrow
  4. Transverse colon
  5. Ascending colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Ascites
  2. Tinea pedis
  3. Disorder of intraocular pressure
  4. Anomaly of chromosome pair 11
  5. Behavior finding
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. EDIL3 protein, human
  2. Gonanes
  3. WZ-4002
  4. AZ-628
  5. GW 5074
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Kmt2a
  2. Mllt3
  3. Hdac7
  4. MAP2K4
  5. DDIT3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Default Mode Network Modulation by Psychedelics: A Systematic Review.
  2. Neural signatures of default mode network in major depression disorder after electroconvulsive thera…
  3. The relationship between the default mode network and the theory of mind network as revealed by psyc…
  4. Resting-state global brain activity affects early β-amyloid accumulation in default mode network.
  5. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
  2. Dose-adjusted EPOCH-R in MYC Positive DLBCL
  3. Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
  4. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients …
  5. BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.